Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 17706
Country/Region: Uganda
Year: 2016
Main Partner: Makerere University
Main Partner Program: Infectious Disease Institute
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $12,735,606 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $2,413,267
Care: Orphans and Vulnerable Children (HKID) $224,605
Care: TB/HIV (HVTB) $431,497
Care: Pediatric Care and Support (PDCS) $744,388
Laboratory Infrastructure (HLAB) $111,400
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $1,698,515
Testing: HIV Testing and Counseling (HVCT) $2,166,099
Sexual Prevention: Other Sexual Prevention (HVOP) $304,921
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $633,548
Treatment: Adult Treatment (HTXS) $3,760,671
Treatment: Pediatric Treatment (PDTX) $246,696
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: <10 Female 2017 280
GEND_GBV Age/Sex: <10 Female 2017 331
GEND_GBV Age/Sex: <10 Male 2017 166
GEND_GBV Age/Sex: <10 Male 2017 197
GEND_GBV Age/Sex: 10-14 Female 2017 765
GEND_GBV Age/Sex: 10-14 Female 2017 913
GEND_GBV Age/Sex: 10-14 Male 2017 166
GEND_GBV Age/Sex: 10-14 Male 2017 197
GEND_GBV Age/Sex: 15-19 Female 2017 1,371
GEND_GBV Age/Sex: 15-19 Female 2017 1,635
GEND_GBV Age/Sex: 15-19 Male 2017 268
GEND_GBV Age/Sex: 15-19 male 2017 334
GEND_GBV Age/Sex: 20-24 Female 2017 1,343
GEND_GBV Age/Sex: 20-24 Female 2017 1,593
GEND_GBV Age/Sex: 20-24 Male 2017 280
GEND_GBV Age/Sex: 20-24 Male 2017 331
GEND_GBV Age/Sex: 25-49 Female 2017 555
GEND_GBV Age/Sex: 25-49 Female 2017 659
GEND_GBV Age/Sex: 25-49 Male 2017 280
GEND_GBV Age/Sex: 25-49 Male 2017 331
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 493
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 587
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 1,208
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 1,437
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 4,266
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 5,084
GEND_GBV Number of people receiving post-GBV care 2017 5,474
GEND_GBV Number of people receiving post-GBV care 2017 6,521
GEND_GBV Sum of Age/Sex Disaggregates 2017 1,377
GEND_GBV Sum of Age/Sex Disaggregates 2017 1,638
HTS_TST Age/sex: <1 2017 3,567
HTS_TST Age/sex: <1 2017 2,648
HTS_TST Age/sex: 1-9 2017 11,732
HTS_TST Age/sex: 1-9 2017 8,729
HTS_TST Age/sex: 10-14 Female 2017 10,134
HTS_TST Age/sex: 10-14 Female 2017 7,546
HTS_TST Age/sex: 10-14 Male 2017 10,101
HTS_TST Age/sex: 10-14 Male 2017 7,546
HTS_TST Age/sex: 15-19 Female 2017 48,553
HTS_TST Age/sex: 15-19 Female 2017 37,782
HTS_TST Age/sex: 15-19 Male 2017 56,102
HTS_TST Age/sex: 15-19 Male 2017 23,122
HTS_TST Age/sex: 20-24 Female 2017 72,834
HTS_TST Age/sex: 20-24 Female 2017 56,687
HTS_TST Age/sex: 20-24 Male 2017 84,155
HTS_TST Age/sex: 20-24 Male 2017 34,692
HTS_TST Age/sex: 25-49 Female 2017 111,669
HTS_TST Age/sex: 25-49 Female 2017 86,916
HTS_TST Age/sex: 25-49 Male 2017 129,042
HTS_TST Age/sex: 25-49 Male 2017 53,196
HTS_TST Age/sex: 50+ Female 2017 9,704
HTS_TST Age/sex: 50+ Female 2017 7,551
HTS_TST Age/sex: 50+ Male 2017 11,224
HTS_TST Age/sex: 50+ Male 2017 4,618
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 17,793
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 13,233
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 17,741
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 13,236
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 242,760
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 188,936
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 280,523
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 115,628
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 558,817
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 331,006
HTS_TST Service Delivery Point (Facility): Index testing 2017 14,493
HTS_TST Service Delivery Point (Facility): Index testing 2017 15,592
HTS_TST Service Delivery Point (Facility): Inpatient 2017 66,612
HTS_TST Service Delivery Point (Facility): Inpatient 2017 94,575
HTS_TST Service Delivery Point (Facility): Other PITC 2017 19,215
HTS_TST Service Delivery Point (Facility): Other PITC 2017 25,139
HTS_TST Service Delivery Point (Facility): Outpatient 2017 108,894
HTS_TST Service Delivery Point (Facility): Outpatient 2017 152,369
HTS_TST Service Delivery Point (Facility): Pediatric 2017 23,485
HTS_TST Service Delivery Point (Facility): Pediatric 2017 32,043
HTS_TST Service Delivery Point (Facility): PMTCT 2017 96,013
HTS_TST Service Delivery Point (Facility): PMTCT 2017 114,401
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 2,294
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 3,205
HTS_TST Service Delivery Point (Facility): VMMC 2017 121,493
HTS_TST Sum of Age/Sex disaggregates 2017 543,518
HTS_TST Sum of Age/Sex disaggregates 2017 319,656
HTS_TST Sum of Aggregated Age/Sex <15 2017 35,534
HTS_TST Sum of Aggregated Age/Sex <15 2017 26,469
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 523,283
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 304,564
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 558,817
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 331,033
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 312
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 250
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 307
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 236
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 1,448
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 1,136
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 1,193
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 643
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 2,176
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 1,713
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 1,789
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 970
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 3,338
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 2,620
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 2,744
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 1,483
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 289
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 219
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 235
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 122
HTS_TST_POS Test Result by Age: Positive: <1 2017 92
HTS_TST_POS Test Result by Age: Positive: <1 2017 66
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 361
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 274
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 550
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 425
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 522
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 401
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 7,251
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 5,688
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 5,961
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 3,218
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 3,545
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 3,545
KP_PREV Total estimated number of key population in the catchment area 2017 6,382
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 6,382
OVC_SERV Age/Sex: 18+ Female 2017 578
OVC_SERV Age/Sex: 18+ Male 2017 480
OVC_SERV By Aggregated Age/Sex: <18 Female 2017 1,653
OVC_SERV By Aggregated Age/Sex: <18 Male 2017 1,545
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 4,256
OVC_SERV Sum of Age/Sex disaggregates 2017 1,058
PMTCT_ART Already on ART at beginning of current pregnancy 2017 2,119
PMTCT_ART Already on ART at beginning of current pregnancy 2017 2,471
PMTCT_ART New on ART 2017 1,524
PMTCT_ART New on ART 2017 1,771
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 97,525
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 116,235
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 2,400
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 2,792
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 630
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 750
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 19
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 27
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 129
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 142
PMTCT_EID Sum of Infant Age disaggregates 2017 3,030
PMTCT_EID Sum of Infant Age disaggregates 2017 3,542
PMTCT_STAT By: Known positives at entry 2017 2,058
PMTCT_STAT By: Known positives at entry 2017 2,407
PMTCT_STAT By: Number of new positives identified 2017 1,736
PMTCT_STAT By: Number of new positives identified 2017 2,029
PMTCT_STAT Number of new ANC and L&D clients 2017 100,017
PMTCT_STAT Number of new ANC and L&D clients 2017 119,206
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 97,525
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 116,235
PMTCT_STAT Sum of Positives Status disaggregates 2017 3,794
PMTCT_STAT Sum of Positives Status disaggregates 2017 4,436
PP_PREV Aggregated Age/sex: <15 Female 2017 3,117
PP_PREV Aggregated Age/sex: <15 Male 2017 2,876
PP_PREV Aggregated Age/sex: 15+ Female 2017 3,660
PP_PREV Aggregated Age/sex: 15+ Male 2017 3,671
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 13,322
PP_PREV Total number of people in the target population 2017 33,011
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 4
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 40
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 229
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 6
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 103
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 464
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 143
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 703
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 143
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 703
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 5,224
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 2,008
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Other (Not Xpert) 2017 191
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 518
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 610
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 1,573
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 1,207
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 3,133
TB_SCREENDX Screen Result: Screened Positive for TB 2017 1,307
TB_SCREENDX Screen Results: Screened Positive for TB 2017 505
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 933
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 817
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 15,438
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 40,181
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 7,931
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 20,690
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 2,315
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 2,054
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 25,119
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 65,240
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 14
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 70
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 296
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,030
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 21
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 95
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 552
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,871
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 883
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 3,066
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 883
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 3,066
TX_CURR Age/Sex: <1 2017 48
TX_CURR Age/Sex: <1 2017 165
TX_CURR Age/Sex: <1-9 2017 1,056
TX_CURR Age/Sex: 1-9 2017 452
TX_CURR Age/Sex: 10-14 Female 2017 674
TX_CURR Age/Sex: 10-14 Female 2017 1,690
TX_CURR Age/Sex: 10-14 Male 2017 576
TX_CURR Age/Sex: 10-14 Male 2017 1,458
TX_CURR Age/Sex: 15-19 Female 2017 774
TX_CURR Age/Sex: 15-19 Female 2017 2,013
TX_CURR Age/Sex: 15-19 Male 2017 239
TX_CURR Age/Sex: 15-19 Male 2017 618
TX_CURR Age/Sex: 20-24 Female 2017 3,551
TX_CURR Age/Sex: 20-24 Female 2017 9,241
TX_CURR Age/Sex: 20-24 Male 2017 1,590
TX_CURR Age/Sex: 20-24 Male 2017 4,137
TX_CURR Age/Sex: 25-49 Female 2017 10,339
TX_CURR Age/Sex: 25-49 Female 2017 26,914
TX_CURR Age/Sex: 25-49 Male 2017 5,704
TX_CURR Age/Sex: 25-49 Male 2017 14,899
TX_CURR Age/Sex: 50+ Female 2017 774
TX_CURR Age/Sex: 50+ Female 2017 2,013
TX_CURR Age/Sex: 50+ Male 2017 398
TX_CURR Age/Sex: 50+ Male 2017 1,036
TX_CURR Aggregated Age/Sex: <15 Female 2017 933
TX_CURR Aggregated Age/Sex: <15 Female 2017 2,315
TX_CURR Aggregated Age/Sex: <15 Male 2017 817
TX_CURR Aggregated Age/Sex: <15 Male 2017 2,054
TX_CURR Aggregated Age/Sex: 15+ Female 2017 15,438
TX_CURR Aggregated Age/Sex: 15+ Female 2017 40,181
TX_CURR Aggregated Age/Sex: 15+ Male 2017 7,931
TX_CURR Aggregated Age/Sex: 15+ Male 2017 20,690
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 25,119
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 65,240
TX_CURR Sum of age/sex disaggregates 2017 2,631
TX_CURR Sum of Age/Sex disaggregations 2017 1,013
TX_CURR Sum of Aggregated Age/Sex <15 2017 1,750
TX_CURR Sum of Aggregated Age/Sex <15 2017 4,369
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 23,369
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 60,871
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 25,119
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 65,240
TX_NEW Aggregated Grouping by Age: <1 2017 12
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 268
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 561
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 212
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 482
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 6,111
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 11,956
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 3,145
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 6,158
TX_NEW By Age/Sex: <1 2017 26
TX_NEW By Age/Sex: 1-9 2017 102
TX_NEW By Age/Sex: 1-9 2017 238
TX_NEW By Age/Sex: 10-14 Female 2017 215
TX_NEW By Age/Sex: 10-14 Female 2017 431
TX_NEW By Age/Sex: 10-14 Male 2017 151
TX_NEW By Age/Sex: 10-14 Male 2017 348
TX_NEW By Age/Sex: 15-19 Female 2017 306
TX_NEW By Age/Sex: 15-19 Female 2017 594
TX_NEW By Age/Sex: 15-19 Male 2017 81
TX_NEW By Age/Sex: 15-19 Male 2017 186
TX_NEW By Age/Sex: 20-24 Female 2017 1,404
TX_NEW By Age/Sex: 20-24 Female 2017 2,748
TX_NEW By Age/Sex: 20-24 Male 2017 621
TX_NEW By Age/Sex: 20-24 Male 2017 1,229
TX_NEW By Age/Sex: 25-49 Female 2017 4,102
TX_NEW By Age/Sex: 25-49 Female 2017 8,011
TX_NEW By Age/Sex: 25-49 Male 2017 2,264
TX_NEW By Age/Sex: 25-49 Male 2017 4,433
TX_NEW By Age/Sex: 50+ Female 2017 299
TX_NEW By Age/Sex: 50+ Female 2017 603
TX_NEW By Age/Sex: 50+ Male 2017 179
TX_NEW By Age/Sex: 50+ Male 2017 310
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 9,736
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 19,157
TX_NEW Sum of Age/Sex disaggregates 2017 9,622
TX_NEW Sum of Age/Sex disaggregates 2017 18,893
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 9,736
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 19,157
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 19,061
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 45,406
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 17,159
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 40,869
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 635
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 1,522
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 553
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 1,350
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 10,537
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 25,076
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 5,434
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 12,921
TX_PVLS Numerator: Indication: Routine 2017 17,159
TX_PVLS Numerator: Indication: Routine 2017 40,869
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 715
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 1,690
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 627
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 1,501
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 11,709
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 27,865
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 6,010
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 14,350
TX_PVLS_den Denominator: Indication: Routine 2017 19,061
TX_PVLS_den Denominator: Indication: Routine 2017 45,406
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 15
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 149
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 56
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 221
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 99
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 250
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 108
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 222
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 103
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 264
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 141
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,032
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 490
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 46
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 21
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,429
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,008
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 6,344
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,617
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 107
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 234
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,155
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,245
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 122
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 290
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 144
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 345
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,129
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4,496
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 5,024
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 8,809
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 13,940
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 7,419
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 15,660
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 8,335
TX_RET_den Age/Sex: <1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 5
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 19
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 60
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 165
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 107
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 247
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 119
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 278
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 114
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 252
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 160
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 296
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 551
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,158
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,134
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,978
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,601
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3,384
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4,064
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 7,130
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 130
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 257
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 290
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 496
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 133
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 326
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 158
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 383
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,396
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 5,051
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 5,648
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 9,900
VMMC_CIRC By Age: 10-14 2017 47,382
VMMC_CIRC By Age: 15-19 2017 35,234
VMMC_CIRC By Age: 20-24 2017 17,009
VMMC_CIRC By Age: 25-29 2017 9,720
VMMC_CIRC By Age: 30-49 2017 9,720
VMMC_CIRC By Age: 50+ 2017 2,428
VMMC_CIRC By circumcision technique: Device-based VMMC 2017 4,692
VMMC_CIRC By circumcision technique: Surgical VMMC 2017 116,801
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 121,493
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2017 121,493
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2017 102,053